Advertisement



More in Pharmacy

Pharmaceutical companies merging are thought to increase drug prices, but research from Iowa City-based University of Iowa seems to dispel this theory when the mergers are between generic drugmakers. 

The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of Guillan-Barré syndrome. 

President-elect Donald Trump has threatened to impose "very high tariffs" on Denmark if the country refuses to allow Greenland to become a part of the U.S., The New York Times reported Jan. 8. 

Johnson & Johnson released results from a phase 3 study, showing that the combination of Rybrevant and Lazcluze significantly improved overall survival in patients with advanced non-small cell lung cancer that has specific epidermal growth factor receptor mutations. 

Health System Owned Specialty Pharmacy Alliance (HOSP) has named Tim Affeldt, PharmD, vice president of specialty/infusion operations at Fairview Pharmacy Services, as its new president. 

Patients on dialysis who take denosumab face a 36% higher risk for major cardiovascular adverse events than patients who take oral bisphosphonates, according to a study published Jan. 6 in Annals of Internal Medicine.

Fosigotifator, an amyotrophic lateral sclerosis drug developed by Calico Life Sciences, a biotech company backed by Google's parent company Alphabet, failed to meet its primary endpoint, according to topline results from the Healey ALS platform trial. 

A new study found that the widespread use of pharmaceuticals is introducing toxic "forever chemicals" into U.S. waterways, with large municipal wastewater treatment plants unable to effectively filter them out, The Washington Post reported Jan. 7. 

Advertisement
Advertisement
Advertisement